Eisai Co., Ltd. (4523.T) Stock Price, News & Chart

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close4,977.00

Open5,123.00

Day range5,123.005,284.00

52-week range3,660.005,284.00

Off day high−0.08%

Off 52-week high−0.08%

Volume2.16M

Avg. volume (3M)1.23M

Market cap1.49T

EPS (TTM)136.78

Forward P/E26.07

P/E ratio (TTM)38.60

Dividend yield3.21% (160.00)

Beta (5Y)-0.09

Shares outstanding282.24M

Short interest—

Earnings dateNov 10, 2026

Analyst target4,603.57

Profit margin4.94%

Against its peers

Compare in full ›

	4523.T	128940.KS	EMCURE.BO	4547.T	6446.TW	005500.KS
Market cap	1.49T	5.90T	424.98B	161.53B	490.25B	257.59B
P/E (TTM)	38.6	—	38.9	14.4	68.2	—
Forward P/E	26.1	—	27.9	17.6	27.0	—
Price/book	1.6	—	8.0	0.7	13.3	—
Dividend yield	3.21%	0.47%	0.17%	3.46%	0.12%	3.91%
1-year change	+14.60%	−7.73%	+59.82%	−6.36%	+179.84%	+2.82%
Today	+6.09%	+9.80%	+3.02%	+3.06%	−5.20%	−0.49%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Eisai's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
Hanmi Pharm. Co., Ltd.128940.KS · Drug Manufacturers - Specialty & Generic	5.90T	465,000.00	+9.80%
Emcure Pharmaceuticals LimitedEMCURE.BO · Drug Manufacturers - Specialty & Generic	424.98B	2,240.15	+3.02%
Kissei Pharmaceutical Co., Ltd.4547.T · Drug Manufacturers - Specialty & Generic	161.53B	3,870.00	+3.06%
PharmaEssentia Corporation6446.TW · Drug Manufacturers - Specialty & Generic	490.25B	1,185.00	−5.20%
Samjin Pharmaceuticals Co., Ltd.005500.KS · Drug Manufacturers - Specialty & Generic	257.59B	20,350.00	−0.49%
Eris Lifesciences LimitedERIS.NS · Drug Manufacturers - Specialty & Generic	170.63B	1,229.90	+1.23%
Betta Pharmaceuticals Co., Ltd.300558.SZ · Drug Manufacturers - Specialty & Generic	20.76B	49.05	+1.62%
Neurocrine Biosciences, Inc.N1BI34.SA · Drug Manufacturers - Specialty & Generic	93.02B	45.95	−0.02%

Other companies in Drug Manufacturers - Specialty & Generic, closest in size first.

Company	Mkt cap	Price	Today
PT Pyridam Farma TbkPYFA.JK · Jakarta Selatan, Indonesia	1.21T	108.00	−4.42%
GC Biopharma Corp.006280.KS · Yongin-Si, South Korea	1.62T	142,300.00	+2.67%
PT Merck TbkMERK.JK · Jakarta Timur, Indonesia	1.58T	3,530.00	+2.92%
Laurus Labs LimitedLAURUSLABS.NS · Hyderabad, India	1.27T	2,346.00	+0.96%
Kyowa Kirin Co., Ltd.4151.T · Chiyoda, Japan	1.37T	2,620.50	+6.07%
Torrent Pharmaceuticals LimitedTORNTPHARM.BO · Ahmedabad, India	1.60T	4,717.95	−0.25%
Zydus Lifesciences LimitedZYDUSLIFE.BO · Ahmedabad, India	1.19T	1,196.40	+0.54%
Celltrion Pharm, Inc.068760.KQ · Cheongju-si, South Korea	1.79T	40,350.00	+6.61%

Healthcare companies of a similar market value (1.42T).

Company	Mkt cap	Price	Today
Seegene, Inc.096530.KQ · Biotechnology	1.45T	31,800.00	+0.95%
Thermo Fisher Scientific Inc.TMOS34.SA · Diagnostics & Research	1.43T	80.15	+0.29%
Regeneron Pharmaceuticals, Inc.REGN.MX · Biotechnology	1.90T	18,330.00	0.00%
Amgen Inc.AMGN34.SA · Drug Manufacturers - General	1.42T	93.78	+3.49%
PT Pyridam Farma TbkPYFA.JK · Drug Manufacturers - Specialty & Generic	1.21T	108.00	−4.42%
GC Biopharma Corp.006280.KS · Drug Manufacturers - Specialty & Generic	1.62T	142,300.00	+2.67%
PT Merck TbkMERK.JK · Drug Manufacturers - Specialty & Generic	1.58T	3,530.00	+2.92%
Laurus Labs LimitedLAURUSLABS.NS · Drug Manufacturers - Specialty & Generic	1.27T	2,346.00	+0.96%

Also based in Tokyo, Japan, then elsewhere in Japan.

Company	Mkt cap	Price	Today
Honda Motor Co., Ltd.HMC.BA · Tokyo, Japan	230.66T	59,250.00	+4.13%
Recruit Holdings Co., Ltd.6098.T · Tokyo, Japan	25.01T	18,010.00	+2.62%
SoftBank Group Corp.9984.T · Tokyo, Japan	22.68T	3,980.00	−6.77%
Sumitomo Mitsui Financial Group, Inc.8316.T · Tokyo, Japan	24.02T	3,191.00	+1.43%
Sony Group Corporation6758.T · Tokyo, Japan	24.59T	4,211.00	+7.07%
Hitachi, Ltd.6501.T · Tokyo, Japan	21.27T	4,772.00	−2.49%
Tokyo Electron Limited8035.T · Tokyo, Japan	19.81T	8,753.00	−9.42%
Mitsubishi Corporation8058.T · Tokyo, Japan	19.32T	5,274.00	+2.45%

The stocks whose daily moves over the past year went most closely with Eisai's: the correlation of their daily returns, where 1 would be moving as one.

Company	Mkt cap	Price	Today
Kyowa Kirin Co., Ltd.4151.T · Correlation 0.46	1.37T	2,620.50	+6.07%
Kissei Pharmaceutical Co., Ltd.4547.T · Correlation 0.45	161.53B	3,870.00	+3.06%
ITOCHU Corporation8001.T · Correlation 0.44	16.54T	2,395.50	+5.48%
Mitsubishi Corporation8058.T · Correlation 0.34	19.32T	5,274.00	+2.45%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All 4523.T news ›

BioSpace·Oct 29Positive

Eisai to Present New Five-Year Lecanemab Data and Real-World Alzheimer's Disease Research at the 19th Clinical Trials on Alzheimer's Disease (CTAD) Conference

TOKYO, Oct. 29, 2026 /PRNewswire/ -- Eisai Co., Ltd. announced today that it will present new Alzheimer's disease (AD) research at the 19th Clinical Trials on Alzheimer's Disease (CTAD) Conference, taking place November 16-19, 2026, in…

MCI BIIB GOOGL TLSA

Eisai Newsroom·Oct 26Negative

Eisai Presents Endometrial Cancer Patient Survey Data at SGO 2026 | Eisai US

70% of patients surveyed reported the burden of chemotherapy treatment was almost as great as the burden of the disease itself, and 71% would prefer not to receive it again Findings indicate that patients desire more discussion about…

MRK

TradingView·Oct 16Positive

Eisai Deepens Its Oncology Evidence Base at ESMO Congress 2026

TradingView Eisai Deepens Its Oncology Evidence Base at ESMO Congress 2026 TOKYO, Oct 16, 2026 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today the presentation of clinical research acr

PFE AZN

MarketScreener·Oct 7Positive

Eisai and Biogen Receive Approval for LEQEMBI Pen Subcutaneous Formulation for Early Alzheimer?s Disease in Japan

Eisai Co., Ltd. and Biogen Inc. announced that LEQEMBI Pen, the subcutaneous formulation of the anti-amyloid beta protofibril antibody LEQEMBI has been approved in Japan as a new route of...

MCI LLY LH DGX

MarketScreener·Oct 7Positive

Eisai, Biogen Secure China's Nod for Self-Injection Version of Leqembi

China's National Medical Products Administration approved Eisai and Biogen's subcutaneous autoinjector version of anti-amyloid beta protofibril antibody Leqembi as an initiation treatment for... Eisai, Biogen Secure China's Nod for…

MCI LLY NVO GOOGL

From the 4Search news index, newest first.